Groundwork laid for First-Ever adult sickle cell stroke prevention trials
NCT ID NCT03376893
Summary
This study aims to understand stroke risk in adults with sickle cell disease, as current prevention guidelines are based on children's data. Researchers will follow 102 adults for several years, tracking who experiences strokes and monitoring brain health. The data collected will help design the first clinical trials specifically focused on preventing strokes in adults with this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-9000, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.